Suven Pharmaceuticals (SUVENPHAR) will hold a Board Meeting on 28 May 25 to consider and approve the audited financial results (standalone and consolidated) for the quarter and financial year ending 31 Mar 25.

Additionally, the trading window for dealing in the company's securities will be closed from 1 Apr 25 to 30 May 25.